ACIU

AC Immune SA (ACIU)

NASDAQ
$3.11
$+0.15
(+5.07%)
AC Immune SA (ACIU) Live Price Chart
Page last updated: 2026-02-06 20:49:00

Key Market Data

$311.77M

$2.98

$19.97

$1.43

$2.96

$+0.15

+5.07%

237K

AC Immune SA (ACIU) Stock Price Today

AC Immune SA (ACIU) is currently trading at $3.11 as of 2026-02-06 20:49:00, reflecting a +5.07% move ($+0.15) from the previous close.

In the short term, the stock has returned -973.84% over the past four weeks. Over the last 12 months, AC Immune SA has recorded a +15.43% price change, indicating a stable performance relative to the broader market.

AC Immune SA (ACIU) 7-Day Stock Price Changes

Over the past seven days, AC Immune SA has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $3.21 to the latest recorded price of $3.11, reflecting an intraday change of +5.07%. Daily movements highlight shifts in trading volume (237,217), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, ACIU has delivered a -973.84% return over the past month and a +15.43% change in the last 12 months, indicating a stable trend relative to its broader sector peers.

How to Buy AC Immune SA (ACIU)

You can buy and trade ACIU on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account
Step 1: Create and Verify Your MEXC Account
Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.
Step 2: Deposit Funds Into Your Account
Step 2: Deposit Funds Into Your Account
Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.
Step 3: Search for ACIU and Execute Your Trade
Step 3: Search for ACIU and Execute Your Trade
Open the trading page, enter ACIU in the search bar, select the amount of ACIU you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is AC Immune SA (ACIU)?

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

AC Immune SA Information

Industry
--
Employees
172
Sector
--
Company Website

Frequently Asked Questions (FAQ)

1.What is the current share price of AC Immune SA?
The latest trading price for AC Immune SA (Common Stock) is $ 3.11, compared with a previous closing price of $ 2.96. That means the stock has moved +5.07% so far today. Intraday price updates and recent trading activity for ACIU can be tracked on the live chart and quote section on this page.
2.Is AC Immune SA stock going up or down?
Looking at recent performances, ACIU has returned -973.84% over the past month, +50.00% over the last six months and +15.43% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe stable price momentum for AC Immune SA stock, but keep in mind that past returns do not guarantee future results.
3.Where does ACIU currently sit relative to its 52-week high and low?
In the most recent 52-week period, AC Immune SA has traded between a low of $ 1.43 and a high of $ 4.00. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether ACIU is currently nearer the top or the bottom of its one-year trading band.
4.How is AC Immune SA classified by sector and industry?
AC Immune SA is classified in the -- sector, within the -- industry group and the -- industry. In practice, this means AC Immune SA is grouped with companies that face similar end-markets, competitive dynamics and regulatory environments. For investors, knowing ACIU's sector and industry classification helps when building diversified portfolios, comparing AC Immune SA with direct peers, and understanding how stock-specific risks such as -- may be influenced by broader trends in the -- sector and -- industry.
5.Where is AC Immune SA listed and how large is it by market value?
AC Immune SA is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 311.77M, the company is classified as a Small-cap stock. Market cap gives a quick sense of AC Immune SA's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.
6.What does ACIU's EPS tell investors about its profitability?
Trailing-twelve-month EPS of -- summarises how much profit AC Immune SA has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.
7.How can I track AC Immune SA's financial performance over time?
To follow AC Immune SA's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how ACIU is performing and how the market is responding.
8.When is AC Immune SA expected to report earnings?
AC Immune SA's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for ACIU, as they provide updated information on revenue, profitability and management's outlook.
9.What usually comes out in AC Immune SA's earnings reports?
AC Immune SA's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether ACIU is meeting, beating or missing expectations.
10.How can I stay informed about AC Immune SA's results and guidance?
You can stay up to date on AC Immune SA by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for ACIU on this page helps you see how new information is being reflected in the stock.
11.Does AC Immune SA pay a regular cash dividend to its shareholders?
AC Immune SA Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor ACIU's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.
12.What are the current dividend yield and dividend payout ratio for ACIU?
Based on the latest earnings data, ACIU has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether AC Immune SA is an attractive income stock. The dividend payout ratio measures what percentage of earnings AC Immune SA distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.
13.What kind of business is AC Immune SA?
AC Immune SA is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.
14.How is ACIU valued in terms of P/E ratio and EPS?
AC Immune SA currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of AC Immune SA's earnings. Comparing ACIU's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as AC Immune SA

Largest Market Cap

See US stocks with the highest market capitalisation

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

ACIU-to-USD Calculator

Amount

ACIU
ACIU
USD
USD

1 ACIU = 3.105 USD